LY-3298176 Class: Dual GIP / GLP-1 receptor agonist
In endocrinology, the best-documented example is the co-administration of a GHRH with a GHRP: the resulting GH release is 2 to 3 times greater than what each peptide would produce alone
When we consider medication, we look at broader health markers such as waist measurements, body fat percentage, and early signs of conditions such as insulin resistance, diabetes, or fatty liver disease
Other telehealth platforms like GoodRx Care, WeightWatchers Clinic, and Ro also offer virtual consultations for GLP-1 prescriptions
Factors that may influence susceptibility include baseline gastrointestinal sensitivity, history of motion sickness or migraine, concurrent medications, and dietary habits